Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma

Background: Proteasome 26S subunit, ATPase gene (PSMC) family members play a critical role in regulating protein degradation and are essential for tumor development. However, little is known about the integrative function and prognostic significance of the PSMC gene family members in lung cancer.Met...

Full description

Bibliographic Details
Main Authors:	Hui Jia, Wen-Jin Tang, Lei Sun, Chong Wan, Yun Zhou, Wei-Zhong Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Genetics
Subjects:	PSMC LUAD prognosis immune immunotherapy chemotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.1017866/full

Similar Items

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (<i>PSMC</i>) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
by: Larissa Haertle, et al.
Published: (2023-01-01)

Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress
by: Ariane Kröll‐Hermi, et al.
Published: (2020-07-01)

Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
by: Feng L, et al.
Published: (2024-02-01)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
by: Huang W, et al.
Published: (2023-08-01)

PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells
by: Xiaoyang Zheng, et al.
Published: (2022-03-01)

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
by: Yiming Ma, et al.
Published: (2022-09-01)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
by: Linbin Hua, et al.
Published: (2023-05-01)

PSMC3 promotes RNAi by maintaining AGO2 stability through USP14
by: Yan Jia, et al.
Published: (2022-12-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
by: Yiwei Liu, et al.
Published: (2021-02-01)

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
by: Liangliang Cai, et al.
Published: (2023-06-01)

Evaluating the Prognostic and Therapeutic Potentials of the Proteasome 26S Subunit, ATPase (PSMC) Family of Genes in Lung Adenocarcinoma: A Database Mining Approach
by: Md. Asad Ullah, et al.
Published: (2022-07-01)

Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
by: Qingke Chen, et al.
Published: (2021-04-01)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
by: Duoduo Xu, et al.
Published: (2022-04-01)

Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma
by: Tingting Zhang, et al.
Published: (2024-04-01)

Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma
by: Hua Huang, et al.
Published: (2022-11-01)

A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients
by: Wu X, et al.
Published: (2021-12-01)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
by: Wentao Zhang, et al.
Published: (2023-08-01)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
by: Yanqi Li, et al.
Published: (2021-09-01)

Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma
by: Songhua Cai, et al.
Published: (2021-08-01)

A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma
by: Hanliang Jiang, et al.
Published: (2020-08-01)

NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma
by: Tingting Qin, et al.
Published: (2023-01-01)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
by: Chang S, et al.
Published: (2021-10-01)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
by: Kui Zang, et al.
Published: (2023-11-01)

Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
by: Lin Y, et al.
Published: (2022-05-01)

PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4
by: Wei Bi, et al.
Published: (2023-11-01)

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma
by: Jinman Zhuang, et al.
Published: (2022-05-01)

A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma
by: Yun-Qiang Zhang, et al.
Published: (2022-05-01)

Pan-Cancer Analysis and Experimental Validation Identify ACOT7 as a Novel Oncogene and Potential Therapeutic Target in Lung Adenocarcinoma
by: Chao Zheng, et al.
Published: (2022-09-01)

Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
by: Mengfeng Liu, et al.
Published: (2022-12-01)

MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy
by: Yongan Song, et al.
Published: (2023-08-01)

CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p
by: Dawei Rong, et al.
Published: (2019-02-01)

Differential expression of PSMC4, SKP1, and HSPA8 in Parkinson’s disease: insights from a Mexican mestizo population
by: Alma C. Salas-Leal, et al.
Published: (2023-12-01)

RS1 gene is a novel prognostic biomarker for lung adenocarcinoma
by: Tao Zhang, et al.
Published: (2022-06-01)

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
by: Jin-xiao Liang, et al.
Published: (2022-12-01)

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma
by: Miao He, et al.
Published: (2023-08-01)

Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis
by: Hao Song, et al.
Published: (2023-06-01)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
by: Feng Li, et al.
Published: (2022-09-01)

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
by: Suping Tang, et al.
Published: (2022-05-01)